Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation

Overview of attention for article published in Transplantation and Cellular Therapy, April 2018

Altmetric Badge

Mentioned by

twitter: 5 X users

Readers on

mendeley: 30 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 13,477 followers.

RT @aamdsif: Eltrombopag for the Treatment of of Refractory Pure Red Cell Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Tran…

27 Apr 2018

Reply Repost Favourite

RT @aamdsif: Eltrombopag for the Treatment of of Refractory Pure Red Cell Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Tran…

27 Apr 2018

Reply Repost Favourite

RT @aamdsif: Eltrombopag for the Treatment of of Refractory Pure Red Cell Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Tran…

26 Apr 2018

Reply Repost Favourite

Eltrombopag for the Treatment of of Refractory Pure Red Cell Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation https://t.co/zWl6qC5rZN

26 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.